Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N O'Higgins

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Enzyme & Protein|January 1, 1996
Urokinase plasminogen activator as a predictor of aggressive disease in breast cancerM J Duffy, C Duggan, T Maguire, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Assay of E-cadherin by ELISA in human breast cancersT M Maguire, S G Shering, E W McDermott, et al.
Irish Journal of Medical Science|March 29, 2002
Safety guidelines for radiolocalised sentinel node resectionN Nugent, A D Hill, M Casey, et al.
Clinical Chemistry|January 1, 1991
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findingsM J Duffy, J P Brouillet, D Reilly, et al.
International Journal of Cancer|March 30, 2000
Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumorsR Hanemaaijer, J H Verheijen, T M Maguire, et al.
Irish Journal of Medical Science|May 8, 2002
Tamoxifen as the primary treatment in elderly patients with breast cancerS B Hooper, A D K Hill, S Kennedy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Continuing medical education in oncology in EuropeJ P Armand, A Costa, J Geraghty, et al.
Journal of Clinical Pathology|December 25, 2003
Factors affecting metastases to non-sentinel lymph nodes in breast cancerF J Fleming, D Kavanagh, T B Crotty, et al.
British Medical Journal|January 19, 1974
Simultaneous combined pancreatic testS Nundy, D Shirley, J S Beales, et al.
British Journal of Cancer|December 22, 2004
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancerB Ryan, N O'Donovan, B Browne, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Enzyme & Protein|January 1, 1996
Urokinase plasminogen activator as a predictor of aggressive disease in breast cancerM J Duffy, C Duggan, T Maguire, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Assay of E-cadherin by ELISA in human breast cancersT M Maguire, S G Shering, E W McDermott, et al.
Irish Journal of Medical Science|March 29, 2002
Safety guidelines for radiolocalised sentinel node resectionN Nugent, A D Hill, M Casey, et al.
Clinical Chemistry|January 1, 1991
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findingsM J Duffy, J P Brouillet, D Reilly, et al.
International Journal of Cancer|March 30, 2000
Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumorsR Hanemaaijer, J H Verheijen, T M Maguire, et al.
Irish Journal of Medical Science|May 8, 2002
Tamoxifen as the primary treatment in elderly patients with breast cancerS B Hooper, A D K Hill, S Kennedy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Continuing medical education in oncology in EuropeJ P Armand, A Costa, J Geraghty, et al.
Journal of Clinical Pathology|December 25, 2003
Factors affecting metastases to non-sentinel lymph nodes in breast cancerF J Fleming, D Kavanagh, T B Crotty, et al.
British Medical Journal|January 19, 1974
Simultaneous combined pancreatic testS Nundy, D Shirley, J S Beales, et al.
British Journal of Cancer|December 22, 2004
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancerB Ryan, N O'Donovan, B Browne, et al.
Pageof 9